日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The efficacy and safety of sacituzumab govitecan in the treatment of breast cancer: a systemic review and meta-analysis of emerging clinical data

沙妥珠单抗戈维替康治疗乳腺癌的疗效和安全性：一项基于新兴临床数据的系统评价和荟萃分析

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1683594
Jiang, Lili; Dai, Youran; Li, Man; Zhao, Zuowei
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Options after progression on first-line CDK4/6 inhibitors in advanced breast cancer patients

晚期乳腺癌患者一线 CDK4/6 抑制剂治疗进展后的治疗选择

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359251336623
Jia, Xiaomeng; Wang, Kainan; Wang, Xueqing; Luo, Yiyang; Liu, Huixin; Zhao, Zuowei; Zhao, Jinbo; Li, Man
CDK4
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Application of sentinel lymph nodes biopsy tracers for breast cancer after neoadjuvant chemotherapy in China: A multicenter, real-world study

中国乳腺癌新辅助化疗后前哨淋巴结活检示踪剂的应用：一项多中心真实世界研究

期刊:iScience
影响因子:4.1
doi:10.1016/j.isci.2025.112889
Qu, Fengjiang; Jiang, Tinghan; Liu, Zhenzhen; Ling, Rui; Zhao, Yi; Yang, Hongjian; Liu, Yunjiang; Liu, Ke; Zhang, Jianguo; Mao, Dahua; He, Jianjun; Yu, Zhigang; Liu, Yinhua; Fu, Peifen; Wang, Jiandong; Jiang, Hongchuan; Zhao, Zuowei; Tian, Xingsong; Cao, Zhongwei; Wu, Kejin; Song, Ailin; Jin, Feng; Wu, Di; Fan, Zhimin
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Bioinformatics analysis of IFI6 as a novel prognostic biomarker and its correlation with immune infiltration in breast cancer.

生物信息学分析 IFI6 作为新型预后生物标志物及其与乳腺癌免疫浸润的相关性。

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-20489-6
Jiang Lili, Xing Chan, Li Man, Zhao Zuowei
肿瘤
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：2025
文献求助 收藏

Mucinous breast cancer organoids: an in vitro research model.

粘液性乳腺癌类器官：一种体外研究模型

期刊:Discover Oncology
影响因子:2.9
doi:10.1007/s12672-025-02586-0
Zhao Dongyi, Zhu Shida, Bai Xue, Li Xuelu, Zhao Zuowei
肿瘤
乳腺癌
发表日期：2025
文献求助 收藏

Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: Is it necessary?

对于新辅助治疗后达到病理完全缓解的临床 N2 期三阴性或 HER2 阳性乳腺癌患者，腋窝淋巴结清扫术是否必要？

期刊:Breast
影响因子:7.9
doi:10.1016/j.breast.2024.103671
Guo, Xuhui; Zhang, Jiao; Gong, Xilong; Wang, Jia; Dai, Hao; Jiao, Dechuang; Ling, Rui; Zhao, Yi; Yang, Hongjian; Liu, Yunjiang; Liu, Ke; Zhang, Jianguo; Mao, Dahua; He, Jianjun; Yu, Zhigang; Liu, Yinhua; Fu, Peifen; Wang, Jiandong; Jiang, Hongchuan; Zhao, Zuowei; Tian, Xingsong; Cao, Zhongwei; Wu, Kejin; Song, Ailin; Jin, Feng; Fan, Zhimin; Liu, Zhenzhen
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Association of a complete breast cancer pathologic response with axillary lymph node metastasis via neoadjuvant chemotherapy: Results from the CSBrS-012 study

新辅助化疗后乳腺癌完全病理缓解与腋窝淋巴结转移的相关性：CSBrS-012 研究结果

期刊:Chinese Medical Journal
影响因子:7.3
doi:10.1097/CM9.0000000000002849
Ma, Le; Gao, Pin; Liu, Zhenzhen; Jiao, Dechuang; Ling, Rui; Xiao, Jingjing; Zhao, Yi; Wang, Yitong; Yang, Hongjian; Liu, Yunjiang; Liu, Ke; Zhang, Jianguo; Li, Guangyan; Mao, Dahua; Deng, Yinglei; He, Jianjun; Amina, Maimaitiaili; Yu, Zhigang; Fei, Wang; Liu, Yinhua; Fu, Peifen; Yao, Minya; Wang, Jiandong; Zhu, Li; Jiang, Hongchuan; Zhao, Zuowei; Tian, Xingsong; Cao, Zhongwei; Ma, Xinyu; Wu, Kejin; Fu, Shaomei; Song, Ailin; Wang, Yanwei; Feng, Jin; Fan, Zhimin
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

mTOR inhibitor introduce disitamab vedotin (RC48-ADC) rechallenge microtubule-chemotherapy resistance in HER2-low MBC patients with PI3K mutation

mTOR抑制剂引入disitamab vedotin（RC48-ADC）可重新挑战HER2低表达且伴有PI3K突变的转移性乳腺癌患者的微管-化疗耐药性

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2024.1312634
Hu, Ye; Chen, Fengxi; Sun, Siwen; Xv, Lingzhi; Wang, Xueqing; Wang, Meiling; Zhao, Shanshan; Zhao, Zuowei; Li, Man
肿瘤
mTOR
HER2
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

A nomogram for predicting pathologic node negativity after neoadjuvant chemotherapy in breast cancer patients: a nationwide, multicenter retrospective cohort study (CSBrS-012)

用于预测乳腺癌患者新辅助化疗后病理淋巴结阴性的列线图：一项全国多中心回顾性队列研究（CSBrS-012）

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2024.1326385
Maimaitiaili, Amina; Li, Yijun; Chai, Na; Liu, Zhenzhen; Ling, Rui; Zhao, Yi; Yang, Hongjian; Liu, Yunjiang; Liu, Ke; Zhang, Jianguo; Mao, Dahua; Yu, Zhigang; Liu, Yinhua; Fu, Peifen; Wang, Jiandong; Jiang, Hongchuan; Zhao, Zuowei; Tian, Xingsong; Cao, Zhongwei; Wu, Kejin; Song, Ailin; Jin, Feng; Wu, Puzhao; He, Jianjun; Fan, Zhimin; Zhang, Huimin
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

The Burden of Peripheral Artery Disease in China From 1990 to 2019 and Forecasts for 2030: Findings From the Global Burden of Disease Study 2019

1990年至2019年中国外周动脉疾病负担及2030年预测：2019年全球疾病负担研究结果

期刊:International Journal of Public Health
影响因子:2.4
doi:10.3389/ijph.2024.1607352
Hu, Ye; Gao, Jiyue; Zhuo, Qiping; Liu, Huixin; Wang, Meiling; Jiang, Nina; Wang, Xueqing; Wang, Kainan; Zhao, Zuowei; Li, Man
发表日期：2024
文献求助 收藏